1.71
0.00%
0.00
Nephros Inc stock is traded at $1.71, with a volume of 33,953.
It is up +0.00% in the last 24 hours and down -6.56% over the past month.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.
See More
Previous Close:
$1.71
Open:
$1.6936
24h Volume:
33,953
Relative Volume:
2.95
Market Cap:
$18.03M
Revenue:
$14.24M
Net Income/Loss:
$-1.58M
P/E Ratio:
-3.5625
EPS:
-0.48
Net Cash Flow:
$827.00K
1W Performance:
-3.93%
1M Performance:
-6.56%
6M Performance:
-21.92%
1Y Performance:
+15.54%
Nephros Inc Stock (NEPH) Company Profile
Name
Nephros Inc
Sector
Industry
Phone
201.343.5202
Address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
Nephros Inc Stock (NEPH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-26-21 | Initiated | B. Riley Securities | Buy |
Nephros Inc Stock (NEPH) Latest News
Medical Water Filter Market Size, Share, Growth and Industry Trends - Third Eye News
Nephros (NASDAQ:NEPH) Stock Price Down 0.7% - Defense World
Peritoneal Dialysis Market Trend and Global Demand 2024 to 2031 - Cineglit
Nephros Shares 2024 Corporate Outlook and Plans - TipRanks
Nephros (NASDAQ:NEPH) Shares Up 0.5% - Defense World
Nephros holds Speculative Buy rating, stock target despite 2Q miss - Investing.com
Nephros holds Speculative Buy rating, stock target despite 2Q miss By Investing.com - Investing.com UK
NEPH (Nephros) 3-Year Revenue Growth Rate : 13.30% (As of Jun. 2024) - GuruFocus.com
Earnings call: Nephros reports mixed Q2 2024 results, focuses on digital tools - Investing.com India
Earnings call: Nephros reports mixed Q2 2024 results, focuses on digital tools - Investing.com
Nephros, Inc. (NASDAQ:NEPH) Q2 2024 Earnings Call Transcript - Insider Monkey
Nephros Second Quarter 2024 Earnings: Misses Expectations - Simply Wall St
US$4.75That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These Results - Yahoo Finance
Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript - Seeking Alpha
Nephros Announces Financial Results for Quarter Ended June 30, 2024 - wallstreet:online
Nephros Announces Financial Results for Quarter Ended June 30, 2024 - StockTitan
NEPH Stock Earnings: Nephros Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace
Nephros (NEPH) to Release Quarterly Earnings on Thursday - Defense World
We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn - Yahoo Finance
Nephros Schedules Second Quarter 2024 Financial Results Conference Call - StockTitan
Nephros (NASDAQ:NEPH) Trading 0.5% Higher - Defense World
We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn - Simply Wall St
Financial Review: Orchestra BioMed (NASDAQ:OBIO) vs. Nephros (NASDAQ:NEPH) - American Banking and Market News
Nephros Inc. (NEPH) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Canada Shine On
Nephros (NASDAQ:NEPH) Trading Up 0.7% - Defense World
Nephros Hires Wes Lobo as Chief Marketing Officer - Quantisnow
Earnings Outlook For Nephros - Quantisnow
Read This Before Selling Nephros, Inc. (NASDAQ:NEPH) Shares - Yahoo New Zealand News
Pleasing Signs As A Number Of Insiders Buy Nephros Stock - Yahoo Finance
GEE Group And 2 Other Stocks Under $3 Insiders Are Buying - MSN
The Price Is Right For Nephros, Inc. (NASDAQ:NEPH) - Yahoo Sport Australia
GEE Group And 2 Other Stocks Under $3 Insiders Are Buying By Benzinga - Investing.com UK
GEE Group And 2 Other Stocks Under $3 Insiders Are BuyingPresidio Property Trust (NASDAQ:SQFT) - Benzinga
Nephros director Amron Arthur H buys $11,176 in company stock By Investing.com - Investing.com UK
Nephros director Amron Arthur H buys $11,176 in company stock By Investing.com - Investing.com
Chembio (CEMI) Jumps: Stock Rises 7.1% - Yahoo Movies UK
Nephros (NASDAQ:NEPH) Stock Rating Reaffirmed by Benchmark - Defense World
Insider Buying: President and CEO Banks Robert R. Jr. Acquires 50,000 Shares of Nephros Inc (NEPH) - Yahoo Finance UK
Insider Buying: President and CEO Banks Robert R. Jr. Acquires 50,000 Shares of Nephros Inc (NEPH) - Yahoo Finance
Analyzing Nephros (NASDAQ:NEPH) and Nevro (NYSE:NVRO) - Defense World
Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates - Simply Wall St
Earnings Update: Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Are Trimming Their Forecasts - Yahoo Finance
Nephros, Inc. announced that it has received $1.5 million in funding from Lambda Investors LLC, - Marketscreener.com
Nephros, Inc. (NEPH) Q1 2024 Earnings Call Transcript - Seeking Alpha
Nephros Inc to Present Corporate Strategies at ShowcaseTipRanks.com - TipRanks
Nephro Care India files DRHP to raise funds via IPO - IndiaTimes
Nephros Full Year 2023 Earnings: Misses Expectations - Yahoo Finance
Nephros, Inc. (NASDAQ:NEPH) Q4 2023 Earnings Call Transcript - Yahoo Finance
Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update - PR Newswire
Market Sentiment Around Loss-Making Nephros, Inc. (NASDAQ:NEPH) - Simply Wall St
What Is Nephros, Inc.'s (NASDAQ:NEPH) Share Price Doing? - Yahoo Finance
Nephros Inc Stock (NEPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):